In the present study, we found 2.1- and 2.9-fold elevation of plasma CXCL13, a specific chemokine ligand for CXCR5, among primary and SLE-related AIHA patients, respectively. This evidence concerns the gene CXCR5 and systemic lupus erythematosus.